Hydroxymethylquinoxalindioxyde

DRUG2 trials

Sponsors

Valenta Pharm JSC

Conditions

InfectionsPyoderma

Phase 1

Safety and Pharmacokinetics of Dioxidin, Solution for Topical and External Use, 0.25 mg/ml and Dioxidin, Solution for Infusion and External Use, 5 mg/ml in Healthy Volunteers

CompletedNCT05505097

Valenta Pharm JSCInfections

Start: 2022-05-04End: 2022-12-19Updated: 2023-08-21

Phase 3

Efficacy and Safety of Dioxidin Versus Miramistin in Superficial Pyoderma

CompletedNCT05561816

Valenta Pharm JSCPyoderma

Start: 2022-07-19End: 2022-12-20Updated: 2023-10-10